3/28
04:19 pm
inmb
INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update [Yahoo! Finance]
Low
Report
INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update [Yahoo! Finance]
3/28
04:01 pm
inmb
INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update
Low
Report
INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update
3/26
04:18 pm
inmb
INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28 [Yahoo! Finance]
Low
Report
INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28 [Yahoo! Finance]
3/26
04:01 pm
inmb
INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28
Low
Report
INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28
3/13
08:12 am
inmb
INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives The ISCT Career Achievement Award in Cell and Gene Therapy [Yahoo! Finance]
Low
Report
INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives The ISCT Career Achievement Award in Cell and Gene Therapy [Yahoo! Finance]
3/13
08:00 am
inmb
INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives The ISCT Career Achievement Award in Cell and Gene Therapy
Low
Report
INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives The ISCT Career Achievement Award in Cell and Gene Therapy
3/5
08:10 am
inmb
INmune Bio Reports Significant EEG Improvement in Alzheimer's Patients Treated with XPro™ [Yahoo! Finance]
Medium
Report
INmune Bio Reports Significant EEG Improvement in Alzheimer's Patients Treated with XPro™ [Yahoo! Finance]
3/5
08:00 am
inmb
INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro™
Medium
Report
INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro™
3/28
04:08 pm
inmb
Form 10-K Inmune Bio, Inc. For: Dec 31
Low
Report
Form 10-K Inmune Bio, Inc. For: Dec 31
3/27
04:08 pm
inmb
Form 8-K Inmune Bio, Inc. For: Mar 26
Low
Report
Form 8-K Inmune Bio, Inc. For: Mar 26
1/30
08:03 am
inmb
Form 8-K Inmune Bio, Inc. For: Jan 30
Medium
Report
Form 8-K Inmune Bio, Inc. For: Jan 30
1/2
04:01 pm
inmb
Form 8-K Inmune Bio, Inc. For: Jan 02
Low
Report
Form 8-K Inmune Bio, Inc. For: Jan 02
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
3/11
Form 10-K Inmune Bio, Inc. For: Dec 31
26.3%
4/24
Form 424B3 Inmune Bio, Inc.
20.9%
10/21
Form 8-K Inmune Bio, Inc. For: Oct 16
13.8%
10/17
INmune Bio, Inc. Announces Presentation of Data Related to its Lead Compound XPro1595 at the Society for Neuroscience’s Annual Meeting
12.2%
12/17
INmune Bio Announces Final Phase I Clinical Data for its Soluble TNF Inhibitor, INB03, Demonstrates Efficacy and Safety; INB03 is Advancing to Phase II Trials
11.8%
9/4
INmune Bio Inc. to Introduce NeuLiv™ Program for Treatment of NASH at H.C. Wainwright 21st Annual Global Investment Conference
10.9%
8/21
Form 4 Inmune Bio, Inc. For: Aug 20 Filed by: Tesi Raymond Joseph
9.1%
4/20
INmune Bio, Inc. Announces Initiation of Clinical Program Targeting Soluble TNF to Determine if the Company’s TNF Inhibitor (DN-TNF) Platform May Prevent Complications of Cytokine Storm Caused by COVID-19
7.7%
9/4
Form 8-K Inmune Bio, Inc. For: Sep 04
7.7%
8/16
Form 3 Inmune Bio, Inc. For: Aug 06 Filed by: Baracchini Edgardo Jr
7.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register